Cite
MLA Citation
J.R. Curtis et al.. “FRI0065 Incidence of Interstitial Lung Disease in Rheumatoid Arthritis Patients Receiving Tocilizumab, Rituximab, Abatacept and Anti-Tumor Necrosis Factor Alpha Agents.” Annals of the rheumatic diseases, vol. 73, 2014, p. 405. http://access.bl.uk/ark:/81055/vdc_100135139003.0x000058